Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- 20FR12B Initial registration of securities (foreign private issuers)
- 1.1 Exhibit 1.1
- 1.2 Exhibit 1.2
- 1.3 Exhibit 1.3
- 1.4 Exhibit 1.4
- 1.5 Exhibit 1.5
- 1.6 Exhibit 1.6
- 1.7 Exhibit 1.7
- 2.1 Exhibit 2.1
- 4.1 Exhibit 4.1
- 4.2 Exhibit 4.2
- 4.5 Exhibit 4.5
- 4.6 Exhibit 4.6
- 4.7 Exhibit 4.7
- 4.8 Exhibit 4.8
- 4.9 Exhibit 4.9
- 4.10 Exhibit 4.10
- 15.1 Exhibit 15.1
- 15.2 Exhibit 15.2
TRIL similar filings
Filing view
External links
Exhibit 15.2
Consent of Independent Auditors
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated September 27, 2012 (except Note 16 as to which the date is August 12, 2014) with respect to the financial statements of Trillium Therapeutics Inc. in the Registration Statement on Form 20-F for the registration of common shares of Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.).
/s/ Ernst & Young LLP | |
Toronto, Canada | Chartered Accountants |
August 12, 2014 | Licensed Public Accountants |